Advertisement

Internal Medicine

Home Internal Medicine
Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment

Gilead Seeks FDA Approval for Remdesivir

Trials of the drug show that it can cut recovery time from COVID-19 by nearly a third
Stephen Hahn

FDA Head Says Any Approved COVID-19 Vaccine Will Be Safe

Assurance was given during a video briefing with the American Medical Association
Use of electronic cigarettes (e-cigarettes) and dual use of cigarettes and e-cigarettes are associated with increased likelihood of COVID-19 diagnosis

E-Cigarette Use Linked to Increased Odds of COVID-19

Dual use of e-cigarettes, cigarettes linked to increased odds of COVID-diagnosis, testing, and symptoms
In an Ideas and Opinions article published online Aug. 11 in the Annals of Internal Medicine

Guidance Helps Doctors Optimize Telemedicine for Seniors

Physicians should be mindful of cues that patient may not hear or understand and repeat or rephrase
Before completing clinical trials to ensure the vaccine is safe and effective

Russia Approves COVID-19 Vaccine Before Trials Completed

President Vladimir Putin claims the vaccine 'works effectively enough'
Alcohol abuse independently increases the risk for mortality in patients with arrhythmia by more than 70 percent

Alcohol Abuse Ups Mortality Risk Among Arrhythmia Patients

Among patients hospitalized for arrhythmia, those with alcohol abuse 72 percent more likely to die
Two-thirds of U.S. adults say they would get a COVID-19 vaccine

Two-Thirds of U.S. Adults Likely to Get COVID-19 Vaccine

However, likelihood varies by geography, race, and other demographic factors
Mental stress-induced inferior frontal lobe activation is associated with angina among patients with coronary artery disease

Mental Stress-Induced Brain Activation Linked to Angina

Mental stress-induced inferior frontal lobe activation linked to angina in stable coronary artery disease
During the early COVID-19 period

Hospitalization Rates for AMI Dropped During Early COVID-19

Reduction at rate of 19.0 cases per week followed by increase at rate of 10.5 cases per week
For patients with gonorrhea

Serine 91 Genotype of gyrA Gonorrhea Successfully Treated With Ciprofloxacin

Efficacy of single-dose oral ciprofloxacin treatment in the per-protocol population was 100 percent